Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05986214 · ClinicalTrials.gov registry record · NA

Developing an Intervention to Optimize Virtual Care Adoption for COPD Management

A NA study, sponsored by VA Office of Research and Development.

Not yet
Registry status
NA
Development phase
40
Enrollment target

NCT05986214: Clinical Trial NA study, sponsored by VA Office of Research and Development.

NCT05986214 is a NA study that has not yet begun recruiting, run by VA Office of Research and Development. The registered enrollment target is 40 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05986214, a NA study, has not yet begun recruiting, sponsored by VA Office of Research and Development.

NOT YET RECRUITING
Registry status
NA
Development phase
40 participants
Enrollment target

Study Summary

VA is a leader in virtual care (VC), including the patient portal, mobile apps, and telehealth programs. VC has great utility for managing chronic conditions like chronic obstructive pulmonary disease (COPD). However, adoption of many VC services has been slow. Lack of awareness about these services is one of the most prominent patient- and healthcare team-facing barriers to adopting VC. This study will develop, refine, and pilot a stakeholder-informed multicomponent implementation strategy to support adoption of VC, referred to as VC-OPTIONS (Virtual Care for Chronic Obstructive Pulmonary Disease Adoption Support). This feasibility trial will pilot the VC-OPTIONS implementation strategy to assess feasibility and acceptability and gather preliminary effectiveness data to inform a larger hybrid effectiveness-implementation trial. The core component of VC-OPTIONS will be the provision of information via VA's Annie texting program to empower patients with knowledge about the array of VC services and how they can be used to support COPD management. It is hypothesized that this strategy will be acceptable and feasible. This work will improve patient and team awareness of and communication about VC services, and support patient access to VC services for COPD management.

Interventions

  • OTHER VC-OPTIONS

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2026-09-01
Est. Completion 2028-08-31
Phase NA

Sponsor

VA Office of Research and Development

1,668 total trials

What the Registry Record Tells You About NCT05986214

The ClinicalTrials.gov registry entry for NCT05986214 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which VC-OPTIONS is the first listed.

NCT05986214 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT05986214 about?

NCT05986214 is a clinical study titled "Developing an Intervention to Optimize Virtual Care Adoption for COPD Management". VA is a leader in virtual care (VC), including the patient portal, mobile apps, and telehealth programs. VC has great utility for managing chronic conditions like chronic obstructive pulmonary disease (COPD). However, adoption of many VC services has been slow. Lack of awareness about these services...

What is the current status of trial NCT05986214?

This trial is currently not yet recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2026-09-01. Estimated completion is 2028-08-31.

What interventions are being tested in trial NCT05986214?

The interventions under investigation include: VC-OPTIONS (OTHER).

Who is sponsoring clinical trial NCT05986214?

This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.